TrippBio Publishes Data Comparing PanCytoVir™ versus Oseltamivir Against H5N1 and H7N9 Pandemic Influenza
AP News,
PanCytoVir™ therapy provided 100% protection against lethal H5N1 infection, complete elimination of H5N1 from the lungs, and a…
PanCytoVir™ therapy provided 100% protection against lethal H5N1 infection, complete elimination of H5N1 from the lungs, and a…
PanCytoVir™ therapy provided 100% protection against lethal H5N1 infection, complete elimination of H5N1 from the lungs, and a…
• PanCytoVir™ demonstrates greater potency against strains of influenza A and B and variants known to be resistant to…
TrippBio, Inc. • PanCytoVir™ demonstrates greater potency against strains of influenza A and B and variants known to be…